Patrick J. Brennan

Active 1967–2025

Also published as
Patrick J Brennan
162
Papers
34,000
Citations
103
h-index
159
i10-index

Citations

Citations per year for Patrick J. Brennan1966: 1 citations1970: 4 citations1971: 1 citations1972: 3 citations1973: 1 citations1974: 2 citations1975: 1 citations1976: 1 citations1977: 2 citations1978: 1 citations1979: 1 citations1980: 2 citations1981: 8 citations1982: 12 citations1983: 10 citations1984: 8 citations1985: 7 citations1986: 18 citations1987: 19 citations1988: 13 citations1989: 25 citations1990: 34 citations1991: 59 citations1992: 57 citations1993: 56 citations1994: 47 citations1995: 81 citations1996: 135 citations1997: 183 citations1998: 173 citations1999: 168 citations2000: 267 citations2001: 324 citations2002: 301 citations2003: 332 citations2004: 318 citations2005: 286 citations2006: 292 citations2007: 338 citations2008: 253 citations2009: 228 citations2010: 237 citations2011: 245 citations2012: 216 citations2013: 234 citations2014: 345 citations2015: 208 citations2016: 230 citations2017: 187 citations2018: 165 citations2019: 659 citations2020: 760 citations2021: 565 citations2022: 413 citations2023: 285 citations2024: 441 citations2025: 178 citations2026: 6 citations1967–1969: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,251 citing papers, 30.7% of this breakdownUnited Kingdom: 893 citing papers, 8.4% of this breakdownFrance: 597 citing papers, 5.6% of this breakdownGermany: 515 citing papers, 4.9% of this breakdownChina: 394 citing papers, 3.7% of this breakdownCanada: 354 citing papers, 3.4% of this breakdownIndia: 317 citing papers, 3% of this breakdownJapan: 295 citing papers, 2.8% of this breakdownAustralia: 278 citing papers, 2.6% of this breakdownNetherlands: 269 citing papers, 2.6% of this breakdownSwitzerland: 262 citing papers, 2.5% of this breakdownItaly: 247 citing papers, 2.3% of this breakdown
0%30.7%Other 27.5%

Fields

  • Medicine50.4%
  • Immunology and Microbiology26%
  • Biochemistry, Genetics and Molecular Biology14.1%
  • Chemistry2.5%
  • Health Professions1.3%
  • Agricultural and Biological Sciences1.2%
  • Other4.5%

Topics

  • Tuberculosis Research and Epidemiology8.1%
  • Mycobacterium research and diagnosis6.8%
  • Immune Cell Function and Interaction4.6%
  • Immune Response and Inflammation3.3%
  • Antibiotic Use and Resistance3%
  • T-cell and B-cell Immunology2.9%
  • Other71.3%

Coauthors

All papers

Open in search
  1. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship

    Authors: , , , , , , , , , , , , - Clinical Infectious Diseases 2006 cited by 3,368

  2. Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions

    Authors: , , - Nature reviews. Immunology 2013 cited by 827

  3. Estimating the Proportion of Healthcare-Associated Infections That Are Reasonably Preventable and the Related Mortality and Costs

    Authors: , , , , , - Infection Control and Hospital Epidemiology 2011 cited by 1,213

  4. THE ENVELOPE OF MYCOBACTERIA

    Authors: , - Annual Review of Biochemistry 1995 cited by 1,927

  5. Regulatory iNKT cells lack expression of the transcription factor PLZF and control the homeostasis of Treg cells and macrophages in adipose tissue

    Authors: , , , , , , , , , , , , , , - Nature Immunology 2014 cited by 368

  6. Practical Guidance for the Evaluation and Management of Drug Hypersensitivity: Specific Drugs

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stephanie Logsdon, Margee Louisias, Andrew J. MacGinnitie, Michelle C. Maciag, Samantha Minnicozzi, Allison E. Norton, Iris M. Otani, Miguel Park, Sarita U. Patil, Elizabeth J. Phillips, Matthieu Picard, Craig D. Platt, Rima Rachid, Tito Rodriguez, Antonino Romano, Cosby A. Stone, Marı́a José Torres, Miriam Verdú, Alberta L. Wang, Paige G. Wickner, Anna R. Wolfson, Johnson T. Wong, Christina Yee, Joseph Zhou, Mariana Castells - The Journal of Allergy and Clinical Immunology In Practice 2020 cited by 222

  7. TCF1–LEF1 co-expression identifies a multipotent progenitor cell (TH2-MPP) across human allergic diseases

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Immunology 2024 cited by 44

  8. Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis

    Authors: - Tuberculosis 2003 cited by 882

  9. Lymphocyte innateness defined by transcriptional states reflects a balance between proliferation and effector functions

    Authors: , , , , , , , , , , , , - Nature Communications 2019 cited by 183

  10. Role of the Major Antigen of Mycobacterium tuberculosis in Cell Wall Biogenesis

    Authors: , , , , , - Science 1997 cited by 734

  11. Locally Informed Simulation to Predict Hospital Capacity Needs During the COVID-19 Pandemic

    Authors: , , , , , , , , , , , , , , - Annals of Internal Medicine 2020 cited by 319

  12. Decaprenylphosphoryl Arabinofuranose, the Donor of the d -Arabinofuranosyl Residues of Mycobacterial Arabinan, Is Formed via a Two-Step Epimerization of Decaprenylphosphoryl Ribose

    Authors: , , , , , , , , , - Journal of Bacteriology 2005 cited by 213

  13. Host Defense Mechanisms Triggered by Microbial Lipoproteins Through Toll-Like Receptors

    Authors: , , , , , , , , , , , , , - Science 1999 cited by 1,671

  14. Early‐life fecal metabolomics of food allergy

    Authors: , , , , , , , , , , , , , , - Allergy 2022 cited by 30

  15. Safety, Costs, and Efficacy of Rapid Drug Desensitizations to Chemotherapy and Monoclonal Antibodies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Journal of Allergy and Clinical Immunology In Practice 2016 cited by 207

  16. Valacyclovir for the Prevention of Cytomegalovirus Disease after Renal Transplantation

    Authors: , , , , , , , , , , , - New England Journal of Medicine 1999 cited by 716

  17. Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment

    Authors: , , , , - Journal of Allergy and Clinical Immunology 2009 cited by 276

  18. Langerhans cells utilize CD1a and langerin to efficiently present nonpeptide antigens to T cells

    Authors: , , , , , , , , , , - Journal of Clinical Investigation 2004 cited by 267

  19. Glycolipid-mediated basophil activation in alpha-gal allergy

    Authors: , , , , , , , , , , , , - Journal of Allergy and Clinical Immunology 2020 cited by 41

  20. Biogenesis of the mycobacterial cell wall and the site of action of ethambutol

    Authors: , , , - Antimicrobial Agents and Chemotherapy 1995 cited by 296

  21. Recognition of the lipid intermediate for arabinogalactan/arabinomannan biosynthesis and its relation to the mode of action of ethambutol on mycobacteria.

    Authors: , , , , - Journal of Biological Chemistry 1994 cited by 267

  22. Unique Structural Features of the Peptidoglycan ofMycobacterium leprae

    Authors: , , , - Journal of Bacteriology 2007 cited by 92

  23. Biomarkers for tuberculosis: the case for lipoarabinomannan

    Authors: , , , , , , , , , - ERJ Open Research 2019 cited by 69

  24. A Two-Cell Model for IL-1β Release Mediated by Death-Receptor Signaling

    Authors: , , , , , - Cell Reports 2020 cited by 32